THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY

eISSN: 2045-1261pISSN: 2045-1253
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

Impact Factor
< 5
5
Time to Publish
time-to-publish View Chart
7  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    SAGE PUBLICATIONS LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    USD 2300
  • Publication Time
    10
  • Editorial Review Process
    Anonymous peer review
General Details
  • Language
    English
  • Society/Institute/Sponsor
    British Association for Psychopharmacology
  • Frequency
    Continuous publication
  • Publication Start Year
    2011
  • Publisher URL
  • Website URL
Publication Details
Editorial Review Detail
Information for authors
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 4%
4-6 13%
7-9 48%
>9 35%

Topics Covered

Disease
Antidepressant
Clozapine
Systematic review
Treatment-resistant depression
Parkinson's disease
Pulmonary embolism
Polypharmacy
Subgroup analysis
Antipsychotic
Bipolar disorder
Postpartum depression
Ketamine
Parkinsonian Symptoms
Neutropenia
Major depressive disorder
Medical history
Safety profile
Quantitative Descriptive Analysis
Confidence interval

Recently Published Papers

Year-wise Publication

FAQs

Since when has THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY been publishing? Faqs

The THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY has been publishing since 2011 till date.

How frequently is the THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY published? Faqs

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY is published Continuous publication.

Who is the publisher of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY? Faqs

The publisher of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY is SAGE PUBLICATIONS LTD.

How can I view the journal metrics of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY on editage? Faqs

For the THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY? Faqs

The eISSN number is 2045-1261 and pISSN number is 2045-1253 for THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Disease, Antidepressant, Clozapine, Systematic review, Treatment-resistant depression, Parkinson's disease, Pulmonary embolism, Polypharmacy, Subgroup analysis, Antipsychotic, Bipolar disorder, Postpartum depression, Ketamine, Parkinsonian Symptoms, Neutropenia, Major depressive disorder, Medical history, Safety profile, Quantitative Descriptive Analysis, Confidence interval.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.